JK08

JK08 · Salubris Biotherapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JK08, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]